Article citationsMore>>

MKC-TI-175 (2013) Trial 175: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Clinical Trial Evaluating the Efficacy and Safety of Prandial Technosphere® Insulin Inhalation Powder versus Technosphere® Inhalation Powder (Placebo) in Insulin Naïve Subjects with Type 2 Diabetes Mellitus Poorly Controlled with Oral Antidiabetic Agents over a 24-Week Treatment Period. Unpublished Manuscript.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top